ハイブリッドイメージング市場：タイプ、用途、最終用途別-2025-2030年の世界予測

ハイブリッドイメージング市場は、2023年に76億2,000万米ドルと評価され、2024年には80億5,000万米ドルに達すると予測され、CAGR 6.56％で成長し、2030年には118億9,000万米ドルに達すると予測されています。

PET-CT、SPECT-CT、MRI-PETなど2つ以上の画像モダリティを組み合わせたハイブリッドイメージング技術は、機能的データと解剖学的データを統合することで診断能力を向上させる。ハイブリッドイメージングの必要性は、複雑な疾患に対する包括的な洞察を提供し、診断ワークフローを合理化し、臨床の精度を向上させるその能力から生まれ、腫瘍学、循環器学、神経学などの分野で極めて重要なものとなっています。その応用範囲は、臨床診断や治療計画から、疾病の進行モニタリングや治療反応の評価まで多岐にわたる。最終用途には、病院、診断センター、研究機関などが含まれ、これらの機関では、患者ケアの向上や臨床研究のサポートにハイブリッドイメージングを活用しています。

市場成長の主な影響要因としては、慢性疾患の有病率の上昇、技術の進歩、精密医療の採用増加、早期かつ正確な診断技術に対する需要の高まりなどが挙げられます。さらに、ヘルスケアインフラ開拓を支援する政府の取り組みや高齢者人口の増加が市場拡大をさらに後押ししています。潜在的なビジネスチャンスは、画像解析と解釈を強化するための画像処理プロセスにおけるAIと機械学習の統合や、個別化医療におけるハイブリッドイメージングの役割拡大にあります。

しかし、市場成長の課題として、高い機器コスト、厳しい規制要件、新興国でのアクセス制限、複雑なシステムを操作するための熟練した専門家の大幅な必要性が挙げられます。イノベーションに意欲的な企業にとっては、高度な製造技術による装置コストの削減、画像処理装置の携帯性とアクセシビリティの向上、AI主導の画像処理ソリューションへの投資などに注力することが、実行可能な道筋を示すことになります。また、感染症や炎症性疾患などの新たな治療分野への応用に関する調査も、市場の拡大を促進する可能性があります。市場は有望な成長軌道を描いているもの、競合市場であるため、戦略的提携、継続的なイノベーション、進化する医療需要と技術的進歩を活用するための市場浸透戦略が求められています。

市場力学：急速に進化するハイブリッドイメージング市場の主要市場インサイトを公開

ハイブリッドイメージング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の有病率の増加
  • 機能的・解剖学的イメージング能力による臨床応用におけるハイブリッドイメージングの使用量の増加
  • マルチモーダル/ハイブリッドイメージング導入に向けた政府の取り組み
• 市場抑制要因
  • ハイブリッドイメージング機器の高コスト
  • 放射線被曝に伴うリスク
• 市場機会
  • 機械学習と人工知能（AI）を画像アプリケーションに統合したハイブリッドイメージングシステムの進歩
  • 障害の早期発見を確実にするための政府の支援投資
• 市場の課題
  • 熟練した訓練を受けた専門家の不足

ポーターのファイブフォース：ハイブリッドイメージング市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ハイブリッドイメージング市場における外部からの影響の把握

外部マクロ環境要因は、ハイブリッドイメージング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ハイブリッドイメージング市場における競合情勢の把握

ハイブリッドイメージング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスハイブリッドイメージング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ハイブリッドイメージング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ハイブリッドイメージング市場における成功への道筋を描く

ハイブリッドイメージング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の増加
    • 機能的および解剖学的画像化能力により、臨床応用におけるハイブリッドイメージングの使用が増加している
    • マルチモーダル/ハイブリッドイメージングの導入に向けた政府の取り組み
  • 抑制要因
    • ハイブリッドイメージングデバイスの高コスト
    • 放射線被曝に伴うリスク
  • 機会
    • 画像処理アプリケーションに機械学習と人工知能（AI）を統合することで、ハイブリッドイメージングシステムを進化させる
    • 障害の早期発見を確実にするための政府の支援投資
  • 課題
    • 熟練した訓練を受けた専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ハイブリッドイメージング市場：タイプ別

• OCT/眼底画像システム
• PET/CTシステム
• PET/MRシステム
• SPET/CTシステム

第7章 ハイブリッドイメージング市場：用途別

• 脳と神経学
• 心臓病学
• 腫瘍学
• 眼科

第8章 ハイブリッドイメージング市場：最終用途別

• 画像診断センター
• 病院

第9章 南北アメリカのハイブリッドイメージング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のハイブリッドイメージング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのハイブリッドイメージング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Bruker Corporation
• CANON MEDICAL SYSTEMS CORPORATION
• Cubresa Inc.
• General Electric Company
• Heidelberg Engineering Inc.
• IMPERIAL LIFE SCIENCES（P）LIMITED
• Koninklijke Philips N.V.
• Kromek Group plc
• Mediso Ltd.
• MR Solutions Ltd.
• NIDEK CO., LTD.
• Siemens AG
• Spectrum Dynamics Medical
• Topcon Corporation
• United Imaging Healthcare Co., Ltd.

LIST OF FIGURES

• FIGURE 1. HYBRID IMAGING MARKET RESEARCH PROCESS
• FIGURE 2. HYBRID IMAGING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HYBRID IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HYBRID IMAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HYBRID IMAGING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HYBRID IMAGING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL HYBRID IMAGING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL HYBRID IMAGING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES HYBRID IMAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES HYBRID IMAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. HYBRID IMAGING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. HYBRID IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HYBRID IMAGING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HYBRID IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HYBRID IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HYBRID IMAGING MARKET DYNAMICS
• TABLE 7. GLOBAL HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HYBRID IMAGING MARKET SIZE, BY OCT/FUNDUS IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HYBRID IMAGING MARKET SIZE, BY PET/CT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HYBRID IMAGING MARKET SIZE, BY PET/MR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HYBRID IMAGING MARKET SIZE, BY SPET/CT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HYBRID IMAGING MARKET SIZE, BY BRAIN & NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HYBRID IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HYBRID IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HYBRID IMAGING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL HYBRID IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL HYBRID IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES HYBRID IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CHINA HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDIA HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA HYBRID IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ITALY HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. POLAND HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. QATAR HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM HYBRID IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM HYBRID IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM HYBRID IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 147. HYBRID IMAGING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. HYBRID IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

The Hybrid Imaging Market was valued at USD 7.62 billion in 2023, expected to reach USD 8.05 billion in 2024, and is projected to grow at a CAGR of 6.56%, to USD 11.89 billion by 2030.

Hybrid imaging technology, which combines two or more imaging modalities such as PET-CT, SPECT-CT, and MRI-PET, offers improved diagnostic capabilities by integrating functional and anatomical data. The necessity for hybrid imaging emerges from its ability to provide comprehensive insights into complex diseases, streamline diagnostic workflows, and enhance clinical accuracy, making it crucial in fields like oncology, cardiology, and neurology. Its application spans from clinical diagnostics and treatment planning to monitoring disease progression and evaluating therapeutic responses. The end-use scope includes hospitals, diagnostic centers, and research institutes, which leverage hybrid imaging to enhance patient care and support clinical research.

Key market growth influencers include the rising prevalence of chronic diseases, technological advancements, increasing adoption of precision medicine, and growing demand for early and accurate diagnostic techniques. Moreover, government initiatives supporting healthcare infrastructure development and the increasing geriatric population further bolster market expansion. Potential opportunities lie in the integration of AI and machine learning in imaging processes to enhance image analysis and interpretation, as well as hybrid imaging's expanding role in personalized medicine.

However, market growth is challenged by high equipment costs, stringent regulatory requirements, limited accessibility in emerging economies, and the significant need for skilled professionals to operate complex systems. For businesses eager to innovate, focusing on reducing equipment costs through advanced manufacturing techniques, enhancing the portability and accessibility of imaging devices, and investing in AI-driven imaging solutions represent viable paths. Further research in hybrid imaging's application in emerging therapeutic areas, such as infectious and inflammatory diseases, can also foster market expansion. Despite its promising growth trajectory, the market's competitive nature calls for strategic collaborations, continuous innovation, and targeted market penetration strategies to capitalize on evolving healthcare demands and technological advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hybrid Imaging Market

The Hybrid Imaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of chronic diseases
  • Growing usage of hybrid imaging in clinical application due to their functional & anatomic imaging abilities
  • Government initiatives for adoption of multimodal/hybrid imaging
• Market Restraints
  • High cost of the hybrid imaging devices
  • Risk associated with radiation exposure
• Market Opportunities
  • Advances in hybrid imaging systems by integrating machine learning and artificial intelligence (AI) for imaging applications
  • Supportive government investments to ensure early detection of disorders
• Market Challenges
  • Shortage of skilled & trained professionals

Porter's Five Forces: A Strategic Tool for Navigating the Hybrid Imaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hybrid Imaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hybrid Imaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hybrid Imaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hybrid Imaging Market

A detailed market share analysis in the Hybrid Imaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hybrid Imaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hybrid Imaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hybrid Imaging Market

A strategic analysis of the Hybrid Imaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hybrid Imaging Market, highlighting leading vendors and their innovative profiles. These include Bruker Corporation, CANON MEDICAL SYSTEMS CORPORATION, Cubresa Inc., General Electric Company, Heidelberg Engineering Inc., IMPERIAL LIFE SCIENCES (P) LIMITED, Koninklijke Philips N.V., Kromek Group plc, Mediso Ltd., MR Solutions Ltd., NIDEK CO., LTD., Siemens AG, Spectrum Dynamics Medical, Topcon Corporation, and United Imaging Healthcare Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Hybrid Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across OCT/Fundus Imaging Systems, PET/CT systems, PET/MR systems, and SPET/CT systems.
• Based on Application, market is studied across Brain & Neurology, Cardiology, Oncology, and Ophthalmology.
• Based on End-Use, market is studied across Diagnostic Imaging Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic diseases
    • 5.1.1.2. Growing usage of hybrid imaging in clinical application due to their functional & anatomic imaging abilities
    • 5.1.1.3. Government initiatives for adoption of multimodal/hybrid imaging
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of the hybrid imaging devices
    • 5.1.2.2. Risk associated with radiation exposure
  • 5.1.3. Opportunities
    • 5.1.3.1. Advances in hybrid imaging systems by integrating machine learning and artificial intelligence (AI) for imaging applications
    • 5.1.3.2. Supportive government investments to ensure early detection of disorders
  • 5.1.4. Challenges
    • 5.1.4.1. Shortage of skilled & trained professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Hybrid Imaging Market, by Type

• 6.1. Introduction
• 6.2. OCT/Fundus Imaging Systems
• 6.3. PET/CT systems
• 6.4. PET/MR systems
• 6.5. SPET/CT systems

7. Hybrid Imaging Market, by Application

• 7.1. Introduction
• 7.2. Brain & Neurology
• 7.3. Cardiology
• 7.4. Oncology
• 7.5. Ophthalmology

8. Hybrid Imaging Market, by End-Use

• 8.1. Introduction
• 8.2. Diagnostic Imaging Centers
• 8.3. Hospitals

9. Americas Hybrid Imaging Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Hybrid Imaging Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Hybrid Imaging Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Bruker Corporation
• 2. CANON MEDICAL SYSTEMS CORPORATION
• 3. Cubresa Inc.
• 4. General Electric Company
• 5. Heidelberg Engineering Inc.
• 6. IMPERIAL LIFE SCIENCES (P) LIMITED
• 7. Koninklijke Philips N.V.
• 8. Kromek Group plc
• 9. Mediso Ltd.
• 10. MR Solutions Ltd.
• 11. NIDEK CO., LTD.
• 12. Siemens AG
• 13. Spectrum Dynamics Medical
• 14. Topcon Corporation
• 15. United Imaging Healthcare Co., Ltd.